| Product Code: ETC10939617 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Serbia Vaccine Market Overview |
3.1 Serbia Country Macro Economic Indicators |
3.2 Serbia Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Serbia Vaccine Market - Industry Life Cycle |
3.4 Serbia Vaccine Market - Porter's Five Forces |
3.5 Serbia Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Serbia Vaccine Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 Serbia Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.8 Serbia Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Serbia Vaccine Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Serbia Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in Serbia |
4.2.2 Government initiatives to improve vaccination coverage |
4.2.3 Rising incidences of infectious diseases in Serbia |
4.3 Market Restraints |
4.3.1 Limited access to vaccines in certain regions of Serbia |
4.3.2 Vaccine hesitancy among a portion of the population |
4.3.3 Lack of infrastructure for cold chain storage and distribution of vaccines |
5 Serbia Vaccine Market Trends |
6 Serbia Vaccine Market, By Types |
6.1 Serbia Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Serbia Vaccine Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Serbia Vaccine Market Revenues & Volume, By Preventive Vaccines, 2021 - 2031F |
6.1.4 Serbia Vaccine Market Revenues & Volume, By Therapeutic Vaccines, 2021 - 2031F |
6.1.5 Serbia Vaccine Market Revenues & Volume, By DNA Vaccines, 2021 - 2031F |
6.2 Serbia Vaccine Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 Serbia Vaccine Market Revenues & Volume, By Influenza, 2021 - 2031F |
6.2.3 Serbia Vaccine Market Revenues & Volume, By COVID19, 2021 - 2031F |
6.2.4 Serbia Vaccine Market Revenues & Volume, By Hepatitis B, 2021 - 2031F |
6.3 Serbia Vaccine Market, By Age Group |
6.3.1 Overview and Analysis |
6.3.2 Serbia Vaccine Market Revenues & Volume, By Pediatrics, 2021 - 2031F |
6.3.3 Serbia Vaccine Market Revenues & Volume, By Adults, 2021 - 2031F |
6.3.4 Serbia Vaccine Market Revenues & Volume, By Geriatrics, 2021 - 2031F |
6.4 Serbia Vaccine Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Serbia Vaccine Market Revenues & Volume, By Intramuscular, 2021 - 2031F |
6.4.3 Serbia Vaccine Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.4.4 Serbia Vaccine Market Revenues & Volume, By Oral, 2021 - 2031F |
6.5 Serbia Vaccine Market, By Technology |
6.5.1 Overview and Analysis |
6.5.2 Serbia Vaccine Market Revenues & Volume, By mRNAbased, 2021 - 2031F |
6.5.3 Serbia Vaccine Market Revenues & Volume, By Viral Vector, 2021 - 2031F |
6.5.4 Serbia Vaccine Market Revenues & Volume, By Protein Subunit, 2021 - 2031F |
7 Serbia Vaccine Market Import-Export Trade Statistics |
7.1 Serbia Vaccine Market Export to Major Countries |
7.2 Serbia Vaccine Market Imports from Major Countries |
8 Serbia Vaccine Market Key Performance Indicators |
8.1 Immunization coverage rate in Serbia |
8.2 Number of vaccination campaigns conducted annually |
8.3 Investment in research and development of new vaccines for diseases prevalent in Serbia |
9 Serbia Vaccine Market - Opportunity Assessment |
9.1 Serbia Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Serbia Vaccine Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.3 Serbia Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.4 Serbia Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Serbia Vaccine Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 Serbia Vaccine Market - Competitive Landscape |
10.1 Serbia Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Serbia Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here